Jiang, Lianggui <br/><br/>
Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma Cells.  [electronic resource] 

 -  PloS one  2015 
 - e0124994 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0124994  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Carcinoma, Hepatocellular--metabolism<br/>Cell Line, Tumor<br/>Drug Synergism<br/>Flavonols--pharmacology<br/>Humans<br/>Liver Neoplasms--metabolism<br/>Organoplatinum Compounds--pharmacology<br/>Proto-Oncogene Proteins c-bcl-2--genetics<br/>Tumor Suppressor Protein p53--genetics